scholarly journals Synthesis of high-molecular-weight aliphatic polycarbonates by organo-catalysis

2016 ◽  
Vol 7 (8) ◽  
pp. 1642-1649 ◽  
Author(s):  
Jingjiang Sun ◽  
Dirk Kuckling

Aliphatic polycarbonates have attracted significant attention for biomedical application over the last few years due to their biodegradability, low toxicity and good biocompatibility.

2019 ◽  
Vol 33 (01n03) ◽  
pp. 1940056
Author(s):  
T. T. Ye ◽  
Q. Y. Deng ◽  
D. L. Ma ◽  
P. C. Li ◽  
B. Huang ◽  
...  

2-methacryloyloxyethyl phosphorylcholine (MPC) polymers have good biocompatibility and hydrophilicity because the function of the phospholipid polar groups of MPC side-chain is similar to the natural articular cartilage. MPC has a potential application on surface modification of artificial joints. In this research, MPC was grafted on ultra-high molecular weight polyethylene (UHMWPE) by the photo-induced graft polymerization to form poly 2-methacryloyloxyethyl phosphorylcholine (PMPC) layer. The microstructure of PMPC layer was studied by Fourier-transform infrared (FT-IR) spectroscopy with attenuated total reflection (ATR) equipment, X-ray photoelectron spectroscopy (XPS). The surface wettability of PMPC layer was evaluated by the contact angle test. The wear resistance of MPC modified UHMWPE was evaluated by the wear test. The results show that the PMPC layer has a good lubricating effect and it can reduce the friction coefficient effectively. The benzophenone pretreatment time is an important factor in the graft stability of MPC.


2021 ◽  
Vol 11 (4) ◽  
pp. 1525
Author(s):  
Matin Rostamitabar ◽  
Gunnar Seide ◽  
Stefan Jockenhoevel ◽  
Samaneh Ghazanfari

Cellulose aerogels (CAs) from plant or bacterial-derived cellulose have advantages such as low density, high porosity, and high specific surface area and have been used in various applications including biomedical fields. One limiting factor in developing CAs is their demanding shaping process since it involves several steps of dissolution/dispersion of cellulose, geometry configurations using molds or nozzles, coagulation and washing of the gel body, and drying techniques. CA fibers can be converted into textiles and enhance the design ability, stiffness, and flexibility of the CAs. This study aims to understand the correlations between the initial cellulose characteristics, aerogel’s internal structure, and its prospective biomedical application. Wet-spun CA fibers were obtained by supercritical CO2 drying from low and high molecular weight microcrystalline cellulose in calcium thiocyanate tetrahydrate solution. Fiber spinning, thermal behavior, textural properties, and biological assessments of the CA fibers were inspected. The CA microfibers from high molecular weight cellulose proved to have a higher surface area (~197 m2/g), denser structure, and finer nanofibrils (~2 nm) with better thermal stability in comparison with the fibers produced from low molecular weight cellulose. The fibers were nontoxic, and cell proliferation was observed over time. CA fibers showed promising results to be used for biomedical applications such as tissue engineering and wound care.


Author(s):  
Richard B. Vallee

Microtubules are involved in a number of forms of intracellular motility, including mitosis and bidirectional organelle transport. Purified microtubules from brain and other sources contain tubulin and a diversity of microtubule associated proteins (MAPs). Some of the high molecular weight MAPs - MAP 1A, 1B, 2A, and 2B - are long, fibrous molecules that serve as structural components of the cytamatrix. Three MAPs have recently been identified that show microtubule activated ATPase activity and produce force in association with microtubules. These proteins - kinesin, cytoplasmic dynein, and dynamin - are referred to as cytoplasmic motors. The latter two will be the subject of this talk.Cytoplasmic dynein was first identified as one of the high molecular weight brain MAPs, MAP 1C. It was determined to be structurally equivalent to ciliary and flagellar dynein, and to produce force toward the minus ends of microtubules, opposite to kinesin.


1993 ◽  
Vol 70 (06) ◽  
pp. 0978-0983 ◽  
Author(s):  
Edelmiro Regano ◽  
Virtudes Vila ◽  
Justo Aznar ◽  
Victoria Lacueva ◽  
Vicenta Martinez ◽  
...  

SummaryIn 15 patients with acute myocardial infarction who received 1,500,000 U of streptokinase, the gradual appearance of newly synthesized fibrinogen and the fibrinopeptide release during the first 35 h after SK treatment were evaluated. At 5 h the fibrinogen circulating in plasma was observed as the high molecular weight fraction (HMW-Fg). The concentration of HMW-Fg increased continuously, and at 20 h reached values higher than those obtained from normal plasma. HMW-Fg represented about 95% of the total fibrinogen during the first 35 h. The degree of phosphorylation of patient fibrinogen increased from 30% before treatment to 65% during the first 5 h, and then slowly declined to 50% at 35 h.The early rates of fibrinopeptide A (FPA) and phosphorylated fibrinopeptide A (FPAp) release are higher in patient fibrinogen than in isolated normal HMW-Fg and normal fibrinogen after thrombin addition. The early rate of fibrinopeptide B (FPB) release is the same for the three fibrinogen groups. However, the late rate of FPB release is higher in patient fibrinogen than in normal HMW-Fg and normal fibrinogen. Therefore, the newly synthesized fibrinogen clots faster than fibrinogen in the normal steady state.In two of the 15 patients who had occluded coronary arteries after SK treatment the HMW-Fg and FPAp levels increased as compared with the 13 patients who had patent coronary arteries.These results provide some support for the idea that an increased synthesis of fibrinogen in circulation may result in a procoagulant tendency. If this is so, the HMW-Fg and FPAp content may serve as a risk index for thrombosis.


1961 ◽  
Vol 06 (01) ◽  
pp. 015-024 ◽  
Author(s):  
Sven Erik Bergentz ◽  
Oddvar Eiken ◽  
Inga Marie Nilsson

Summary1. Infusions of low molecular weight dextran (Mw = 42 000) to dogs in doses of 1—1.5 g per kg body weight did not produce any significant changes in the coagulation mechanism.2. Infusions of high molecular weight dextran (Mw = 1 000 000) to dogs in doses of 1—1.5 g per kg body weight produced severe defects in the coagulation mechanism, namely prolongation of bleeding time and coagulation time, thrombocytopenia, pathological prothrombin consumption, decrease of fibrinogen, prothrombin and factor VII, factor V and AHG.3. Heparin treatment of the dogs was found to prevent the decrease of fibrinogen, prothrombin and factor VII, and factor V otherwise occurring after injection of high molecular weight dextran. Thrombocytopenia was not prevented.4. In in vitro experiments an interaction between fibrinogen and dextran of high and low molecular weight was found to take place in systems comprising pure fibrinogen. No such interaction occurred in the presence of plasma.5. It is concluded that the coagulation defects induced by infusions of high molecular weight dextran are due to intravascular coagulation.


1982 ◽  
Vol 47 (03) ◽  
pp. 197-202 ◽  
Author(s):  
Kurt Huber ◽  
Johannes Kirchheimer ◽  
Bernd R Binder

SummaryUrokinase (UK) could be purified to apparent homogeneity starting from crude urine by sequential adsorption and elution of the enzyme to gelatine-Sepharose and agmatine-Sepharose followed by gel filtration on Sephadex G-150. The purified product exhibited characteristics of the high molecular weight urokinase (HMW-UK) but did contain two distinct entities, one of which exhibited a two chain structure as reported for the HMW-UK while the other one exhibited an apparent single chain structure. The purification described is rapid and simple and results in an enzyme with probably no major alterations. Yields are high enough to obtain purified enzymes for characterization of UK from individual donors.


1984 ◽  
Vol 52 (03) ◽  
pp. 221-223 ◽  
Author(s):  
M Christe ◽  
P Gattlen ◽  
J Fritschi ◽  
B Lämmle ◽  
W Berger ◽  
...  

SummaryThe contact phase has been studied in diabetics and patients with macroangiopathy. Factor XII and high molecular weight kininogen (HMWK) are normal. C1-inhibitor and also α2-macroglobulin are significantly elevated in diabetics with complications, for α1-macroglobulin especially in patients with nephropathy, 137.5% ± 36.0 (p <0.001). C1-inhibitor is also increased in vasculopathy without diabetes 113.2 ± 22.1 (p <0.01).Prekallikrein (PK) is increased in all patients’ groups (Table 2) as compared to normals. PK is particularly high (134% ± 32) in 5 diabetics without macroangiopathy but with sensomotor neuropathy. This difference is remarkable because of the older age of diabetics and the negative correlation of PK with age in normals.


Sign in / Sign up

Export Citation Format

Share Document